Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
SMC2231 09/09/2019 eribulin (Halaven) Non submission

Treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease.
1065/15 06/03/2016 eribulin (Halaven) Resubmission For the treatment of adult patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting unless patients were not suitable for these treatments.
726/11 10/10/2011 eribulin mesylate (Halaven) Full For the treatment of patients with locally advanced breast cancer (LABC) or metastatic breast cancer (MBC), who have progressed after at least two chemotherapeutic regimens for advance disease.

No medicines have been found.